5‐(6,7‐Dimeth­oxy‐1,2,3,4‐tetra­hydro­isoquinolin‐2‐yl)‐4‐phenyl‐1,2,5‐oxadiazole N‐oxide

By  

Acta Crystallographica Section E, Vol. 62, Iss. 7, 2006-07 ,pp. : o3130-o3132

John Wiley & Sons Inc

Access to resources Recommend Favorite

A 1:1 cocrystal of (1R,3S,4S,6R)‐1,2,3,4,5,6‐hexa­bromo‐1,2,3,4,5,6‐hexa­hydro­penta­lene and (1R,2R,4S,5S)‐1,2,3,4,5,6‐hexa­bromo‐1,2,4,5‐tetra­hydro­penta­lene

By  

Acta Crystallographica Section E, Vol. 62, Iss. 6, 2006-06 ,pp. : o2466-o2468

John Wiley & Sons Inc

Access to resources Recommend Favorite

(3R,4R)‐(–)‐3‐Hydroxy­methyl‐4‐phenyl‐2‐o‐toluoyl‐1,2,3,4‐tetra­hydro­isoquinoline

By  

Acta Crystallographica Section E, Vol. 62, Iss. 5, 2006-05 ,pp. : o1774-o1776

John Wiley & Sons Inc

Access to resources Recommend Favorite

Methyl (2S)‐2‐[2‐(5‐fluoro‐2,4‐dioxo‐1,2,3,4‐tetra­hydro­pyrimidin‐1‐yl)acetamido]propionate monohydrate

By  

Acta Crystallographica Section E, Vol. 62, Iss. 5, 2006-05 ,pp. : o1745-o1746

John Wiley & Sons Inc

Access to resources Recommend Favorite

(+)‐(1S,2S,3S,4R,5R)‐N‐(1,3‐Di­hydroxy­prop‐2‐yl)‐2,3,4‐tri­hydroxy‐5‐(hydroxy­methyl)‐1‐cyclo­hexanaminium picrate

By  

Acta Crystallographica Section E, Vol. 61, Iss. 5, 2005-05 ,pp. : o1498-o1500

John Wiley & Sons Inc

Access to resources Recommend Favorite